Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty

Florence Comite, Ora H. Pescovitz, Kenneth G. Rieth, Andrew J. Dwyer, Karen Hench, Ann McNemar, D. Lynn Loriaux, Gordon B. Cutler

Research output: Contribution to journalArticlepeer-review

55 Scopus citations


A long-acting analog of LRH (LRHa) has been shown to suppress pituitary gonadotropin and estradiol secretion to prepubertal levels in girls with idiopathic true precocious puberty. We treated six boys, aged 1–6 yr, with true precocious puberty due to hypothalamic hamartoma for 6–24 months with daily sc injections of LRHa. The patients had enlarged testes (6–25 ml), Tanner stage II-IV pubic hair, facial and axillary hair, increased growth rate, and an advanced bone age. Frequent erections occurred in all patients. Computed tomography of the head showed abnormalities characteristic of hypothalamic hamartoma (0.5–3 cm in diameter) in each boy. Each patient had measurable LH and FSH levels, with pulsed nocturnal secretion, and pubertal LH and FSH responses to LRH. Serum testosterone testosterone was in the range for normal adult men (200–600 ng/dl). LRHa significantly decreased basal LH (P < 0.005) and FSH levels (P < 0.01), LRH-stimulated gonadotropin levels (P < 0.005), and serum testosterone levels (P < 0.005). Testis size decreased significantly (P < 0.005). Annualized growth velocity (centimeters per yr) decreased significantly compared to the pretreatment growth rate (P < 0.01). Bone age advancement per yr slowed significantly during the course of LRHa treatment (P < 0.01). Pubic hair, facial hair, and erections decreased in all patients. LRHa is an effective treatment for boys with precocious puberty associated with hypothalamic hamartoma. Chronic therapy will be required, however, to assess the ultimate effect of LRHa.

Original languageEnglish (US)
Pages (from-to)888-892
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Issue number5
StatePublished - Nov 1984
Externally publishedYes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty'. Together they form a unique fingerprint.

Cite this